Commonwealth Equity Services
RGLS

Commonwealth Equity Services’s Regulus Therapeutics RGLS Stock Holding History

Commonwealth Equity Services’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,700
Closed -$18K – 4270
2024
Q4 		$18K Buy
11,700
+200
+2% +$307 ﹤0.01% 4050
2024
Q3 		$18K Sell
11,500
-6,500
-36% -$10.8K ﹤0.01% 4005
2024
Q2 		$32K Hold
18,000
– – ﹤0.01% 3932
2024
Q1 		$52K Buy
18,000
+500
+3% +$815 ﹤0.01% 3887
2023
Q4 		$22K Hold
17,500
– – ﹤0.01% 3813
2023
Q3 		$24K Hold
17,500
– – ﹤0.01% 3720
2023
Q2 		$26K Hold
17,500
– – ﹤0.01% 3729
2023
Q1 		$14K Hold
17,500
– – ﹤0.01% 3699
2022
Q4 		$23K Sell
17,500
-16,000
-48% -$25.2K ﹤0.01% 3589
2022
Q3 		$56K Buy
33,500
+11,500
+52% +$20.7K ﹤0.01% 3471
2022
Q2 		$45K Buy
22,000
+8,900
+68% +$21.6K ﹤0.01% 3502
2022
Q1 		$39K Buy
13,100
+1,200
+10% +$3.12K ﹤0.01% 3608
2021
Q4 		$37K Buy
11,900
+800
+7% +$3.56K ﹤0.01% 3561
2021
Q3 		$76K Buy
11,100
+3,100
+39% +$22.7K ﹤0.01% 3455
2021
Q2 		$65K Buy
8,000
+6,000
+300% +$67K ﹤0.01% 3442
2021
Q1 		$31K Buy
+2,000
New +$29.6K ﹤0.01% 3360

Other funds holding RGLS

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Commonwealth Equity Services's RGLS Position: Q1 2025 in Review

Commonwealth Equity Services sold out of Regulus Therapeutics (RGLS) in Q1 2025, closing a stake of 11,700 shares — an estimated $18K sold.

Commonwealth Equity Services first reported a position in RGLS in Q1 2021 and held it in 16 quarters. The position peaked at $76K in Q3 2021. 75 funds tracked by Wall St. Rank hold RGLS as of Q1 2025.

  • Commonwealth Equity Services reported no remaining Regulus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 11,700 Regulus Therapeutics shares in Q1 2025, an estimated $18K.
  • Commonwealth Equity Services first reported a position in Regulus Therapeutics in Q1 2021 and held it in 16 quarters.
  • Commonwealth Equity Services's Regulus Therapeutics position peaked at $76K in Q3 2021.
  • 75 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q1 2025.

Based on Commonwealth Equity Services's 13F filing for Q1 2025, filed 9 May 2025.